DIVA Laboratories, Ltd. (TPEX:4153)
33.55
-0.35 (-1.03%)
Feb 11, 2026, 1:30 PM CST
DIVA Laboratories Revenue
DIVA Laboratories had revenue of 196.99M TWD in the quarter ending September 30, 2025, with 1.74% growth. This brings the company's revenue in the last twelve months to 862.38M, up 2.19% year-over-year. In the year 2024, DIVA Laboratories had annual revenue of 862.32M, down -3.53%.
Revenue (ttm)
862.38M
Revenue Growth
+2.19%
P/S Ratio
2.28
Revenue / Employee
5.60M
Employees
154
Market Cap
1.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 862.32M | -31.52M | -3.53% |
| Dec 31, 2023 | 893.84M | -55.36M | -5.83% |
| Dec 31, 2022 | 949.20M | 236.97M | 33.27% |
| Dec 31, 2021 | 712.23M | -24.69M | -3.35% |
| Dec 31, 2020 | 736.93M | 20.76M | 2.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| BenQ Medical Technology | 5.20B |
| OK Biotech | 1.64B |
| Medical Imaging | 1.12B |
| Chunghwa Chemical Synthesis & Biotech | 977.79M |
| Crystalvue Medical | 905.73M |
| GeneFerm Biotechnology | 654.88M |